Founded in 2012, Neurotrack holds an exclusive license for the technology behind its innovative behavioral test from Emory University, following the favorable outcome of an NIH-sponsored longitudinal study. Neurotrack was accepted into Rock Health's Boston class in the summer of 2012, and won 'Best Company' in the SXSW Digital Health competition. The company raised a seed investment round in the spring of 2013.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/26/13 | $2,000,000 | Series A |
Founders Fund Social+Capital Partnership | undisclosed |
| 01/28/16 | $6,500,000 |
AME Cloud Ventures Founders Fund iSeed Ventures Khosla Ventures Social Capital | undisclosed | |
| 03/20/18 | $13,700,000 | Series B |
AME Cloud Ventures Founders Fund Khosla Ventures Marc Benioff Social Capital Sozo Ventures  | undisclosed |
| 06/11/19 | $21,000,000 | Series C |
AME Cloud Ventures Dai-ichi Life Khosla Ventures Sompo Holdings Sozo Ventures | undisclosed |
